NEW PHARMACIST PARENTERAL CERTIFICATION

Overview

On December 31, 2020, the Board published changes to 680-X-2-.19 Parenteral Sterile Therapy. All pharmacists engaged in compounding and dispensing of product which should be sterile, including cytotoxic agents, shall register each renewal cycle with the Board of Pharmacy. After January 1, 1994, pharmacists who have not successfully completed a certifying course for sterile compounding approved by the Board, will not be registered as sterile compounding pharmacists until they have completed said certifying course. Initial training programs submitted for certification shall be a minimum of eight (8) contact hours, including didactic and hands on experience. All programs certified by the Board shall require a written exam as a part of the training. Pharmacists performing high risk sterile compounding shall complete an additional four (4) hour board approved high risk program. All pharmacists approved by the Alabama State Board of Pharmacy as sterile compounding pharmacists must successfully complete two (2) continuing education hours approved by the Board including didactic and hands on training each renewal cycle. It shall be the responsibility of the supervising pharmacist to verify the parenteral certification of pharmacists involved in the preparation of parenteral products.

Board-approved Training Programs

To have your initial or renewal program approved, please email parenteral@albop.com with the subject line indicating facility name and whether you’re submitting for initial training or renewal training approval.

Steps for Notifying the Board of Completion

Coming soon